© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 100.28% of AVTE shares are held by financial institutions. POINT72 ASSET MANAGEMENT, L.P. is the top corporate investor, holding 399.82K shares valued at $11.82M. A 1.44% stake in Aerovate Therapeutics, Inc. is owned by the company. OCTAGON CAPITAL ADVISORS LP owns 403.69K shares valued at $11.94M, which translates its holding of 1.46% of the stake in the company.
Among the AVTE insiders holding of 0.02% of the stake in company, RA CAPITAL MANAGEMENT, L.P., , holds the largest shares of 7.89M. GRAYZEL DAVID S., director, is the second largest AVTE insider with ownership of 14.5K shares. GILLIES HUNTER, CHIEF MEDICAL OFFICER, stands third with possession of 5.6K shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own AVTE shares is 118, representing 100.28% of the company's common stock.
POINT72 ASSET MANAGEMENT, L.P., in the last quarter, reduced its stake in AVTE by -9.43% restricting it's holding to 399.82 thousand shares of worth nearly $11.82M. ORBIMED ADVISORS LLC also lessened -25.31% of the AVTE shares from its portfolio, reducing its holding to 565.37 thousand shares of worth $16.72M. DRIEHAUS CAPITAL MANAGEMENT LLC also shunned AVTE shares holding by -24.87% last quarter which brought its holding to 794.99 thousand shares worth $23.51M.
As per its latest 13F filing, EVENTIDE ASSET MANAGEMENT, LLC increased its stake in AVTE by 3,558.24% in the last quarter. The institutional holder raised its holding to 445.5 thousand shares having worth more than $13.17M. PDT PARTNERS, LLC also added 100% more shares of AVTE to its portfolio, raising its holding to 12.68 thousand shares of worth $374.95K. RHUMBLINE ADVISERS also increased its AVTE shares holding by 3.28% which brought its holding to 14.62 thousand shares worth $432.36K.
The insider with the most stakes in AVTE is RA CAPITAL MANAGEMENT, L.P. , at the company. Additionally, AVTE stock is highly held by director GRAYZEL DAVID S. and CHIEF MEDICAL OFFICER Gillies Hunter among others.
Company executives, directors, and other insiders own 0.02% percent of Aerovate Therapeutics, Inc.'s stock. Within the last six months, there have been 5 transaction(s) in which AVTE insiders have sold stock, totaling 32.98K shares. Insiders that have sold shares include ELDRIDGE GEORGE A, VERWIJS MARINUS, and GILLIES HUNTER.
There have been 1 transaction(s) during the past 6-months in which Aerovate Therapeutics, Inc. insiders have bought stock, totalling 928110 shares
Around 7.91M Aerovate Therapeutics, Inc. shares are held by insiders, which represents about 0.02% of AVTE stock.
AVTE , RA CAPITAL MANAGEMENT, L.P. holds the largest portfolio of the company's shares. AVTE shares owned by RA total nearly 7.89 million.
POINT72 ASSET MANAGEMENT, L.P. is the largest institutional owner in AVTE which holds 399.82 thousand shares worth $11.82M or 1.44% of the total AVTE shares outstanding followed by OCTAGON CAPITAL ADVISORS LP with ownership of 403.69 thousand shares representing 1.46% of the AVTE ownership. EVENTIDE ASSET MANAGEMENT, LLC is the third largest stakeholder with 445.5 thousand shares or 1.61% of the ownership worth more than $13.17M.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the AVTE is concerned, it is a stock which is optionable.
Number of AVTE shares short is 664.99K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 28.87M shares of AVTE are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, AVTE has 11.85M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for AVTE is 2.99.